Cover Image
市場調查報告書

切片設備:技術及全球市場

Biopsy Devices: Technology and Global Markets

出版商 BCC Research 商品編碼 305964
出版日期 內容資訊 英文 141 Pages
訂單完成後即時交付
價格
Back to Top
切片設備:技術及全球市場 Biopsy Devices: Technology and Global Markets
出版日期: 2016年03月28日 內容資訊: 英文 141 Pages
簡介

全球切片設備市場2015年達到15億美元。該市場預計今後以年複合成長率6.2%的規模擴大,預計2020年達21億美元。

本報告提供全球切片設備市場概要與市場趨勢,近幾年的市場資料,今後的市場預測,各市場區隔分析,專利趨勢,產業的主要參與企業的總括的簡介等彙整資料。

第1章 簡介

第2章 摘要整理

第3章 切片設備市場概要

  • 乳房疾病的真空補助下乳房切片系統所扮演的角色
  • 慢性肝疾病的肝臟切片檢查的適應趨勢
  • 影像誘導前列腺切片檢查:傳統技術和新興技術
  • 前列腺切片檢查趨勢
  • 癌症診斷與影像市場(乳房X光攝影、大腸內視鏡、內視鏡)
  • 切片設備市場的法律規章方案
  • 償付方案
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會/課題
  • 案例研究

第4章 切片設備市場:各類型

  • 乳房切片設備
  • 腸胃切片檢查
  • 軟組織切片穿刺針
  • 支氣管切片設備
  • 婦產科切片設備
  • 機器人指導系統
  • 其他

第5章 切片設備市場:各治療領域

  • 乳房切片
  • 前列腺切片檢查
  • 肝臟切片檢查
  • 肺切片檢查
  • 腎切片檢查
  • 婦產科切片檢查
  • 其他

第6章 切片設備市場:影像誘導各技術

  • 誘導切片檢查上使用的影像技術
  • 超音波誘導切片檢查
  • CT(綜合計算斷層掃描)
  • 其他

第7章 切片設備:終端用戶市場

  • 診斷中心
  • 醫院

第8章 競爭環境

  • 產品上市
  • 聯盟及合作
  • 收購
  • 擴大

第9章 切片設備市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第10章 專利分析

第11章 企業簡介

  • ARGON MEDICAL DEVICES INC.
  • BECTON DICKINSON AND CO. (CAREFUSION CORP.)
  • BOSTON SCIENTIFIC CORP.
  • C. R. BARD INC.
  • CARDINAL HEALTH INC.
  • COOK MEDICAL INC.
  • DTR MEDICAL LTD.
  • ETHICON ENDO-SURGERY INC.
  • FUJIFILM Holdings
  • HOLOGIC INC.
  • INRAD INC.
  • INTACT MEDICAL CORP.
  • LEICA BIOSYSTEMS (DEVICOR MEDICAL PRODUCTS)
  • MAUNA KEA TECHNOLOGIES
  • MDNA LIFE SCIENCES INC. (MITOMICS INC.)
  • MDXHEALTH INC.
  • MEDTRONIC
  • SANARUS TECHNOLOGIES LLC
  • VERAN MEDICAL TECHNOLOGIES

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC171B

REPORT HIGHLIGHTS

The global market for biopsy devices should reach around roughly $2.1 billion by 2020 from over $1.5 billion in 2015, a compound annual growth rate (CAGR) of 6.2% from 2015 to 2020.

This report provides:

  • An overview of the global biopsy devices market.
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
  • Segmented analyses based on devices, therapeutic segments, and geographies
  • Information on key devices such as breast biopsy devices, CNB (core needle biopsy) devices, fine needles, gastro intestinal (GI) biopsy devices, robotic guidance systems technologies involved in thermal ablation techniques and non-thermal ablation techniques
  • Analyses of key strategies, competitive insights, and developments of key companies in the market
  • Information on both the challenges that must be addressed and opportunities that can be leveraged by market participants
  • Evaluation of key and relevant patents
  • Analysis of the key strategies, competitive insights and development of key companies in the market

SCOPE OF THE REPORT

This research report presents an in-depth analysis of the global market for biopsy devices by device type, therapeutic segments and geographic markets. It discusses key devices such as breast biopsy devices, core needle biopsy (CNB) devices, fine needles, gastrointestinal (GI) biopsy devices, robotic guidance systems technologies involved in thermal ablation techniques and nonthermal ablation techniques. The market by type of procedure is also discussed, which includes trends and market estimates of key therapeutic areas such as breast cancer, gastrointestinal cancer, lung cancer and cervical cancer, among others. The report focuses on key imaging technologies used in the process of performing biopsies such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and others. The report also reviews the supply chain from manufacturers to surgeons.

The report excludes drugs used during a biopsy and any device that is used in the cancer treatment process.

ANALYST'S CREDENTIALS

Yojana Jeevane has more than four years of experience in market intelligence and business research. She has experience in the healthcare domain with respect to medical devices, the life sciences market and chemical domain. Ms. Jeevane has provided research services that contain strategic recommendations to assist market players in making beneficial decisions. Yojana holds a B.Sc in Biotechnology and an MBA in Marketing.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY OBJECTIVES
  • STUDY BACKGROUND
  • SCOPE OF THE REPORT
  • INTENDED AUDIENCE
  • METHODOLOGY AND INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, 2014-2020 ($ MILLIONS)

CHAPTER 3 - OVERVIEW OF BIOPSY DEVICE MARKET

  • VACUUM-ASSISTED BREAST BIOPSY
    • ADVANTAGES OF VAB TECHNIQUE
    • DISADVANTAGES OF VAB TECHNIQUE
  • LIVER BIOPSY TRENDS
    • LIVER DISEASE FACTS
    • PERCUTANEOUS LIVER BIOPSY
    • LAPAROSCOPIC SURGERY
  • PROSTATE BIOPSY TRENDS
    • IMAGE-GUIDED PROSTATE BIOPSY
    • RISKS OF BIOPSY OF THE PROSTATE
  • CANCER DIAGNOSTICS AND IMAGING
    • MAMMOGRAPHY
    • COLONOSCOPY
    • ENDOSCOPY
  • REGULATION OF BIOPSY DEVICES
    • U.S. REGULATION OF BIOPSY DEVICES
    • EU REGULATION OF BIOPSY DEVICES
      • Breast Cancer
        • TABLE 1: IMPLEMENTATION OF BREAST CANCER SCREENING PROGRAMS BY COUNTRY
      • Gastroenterology and Urology
    • REIMBURSEMENT POLICIES
      • U.S. REIMBURSEMENT FOR BREAST CANCER SCREENING
      • U.S. REIMBURSEMENT FOR BREAST RECONSTRUCTION OR PROSTHESIS
      • U.S. REIMBURSEMENT UNDER THE WHCRA
      • U.S. REIMBURSEMENT UNDER THE AFFORDABLE CARE ACT
  • MARKET DYNAMICS
    • DRIVERS
      • Increase in Prevalence of Chronic Diseases
      • Minimally Invasive Procedures as Compared with Other Techniques
      • Increased Public Awareness of Disease Screening
      • Increasing Aging Population
        • TABLE 2: GLOBAL TRENDS IN AGING POPULATION BY REGION, 1980-2040 (%)
        • FIGURE 1: GLOBAL TRENDS IN AGING POPULATION, 1980-2040 (%)
      • Strong Reimbursement Policies in Developing Economies
      • Technological Advancements in Imaging Technology
    • RESTRAINTS
      • Increased Competition from Other Cancer Diagnostic Tests
      • High Price of Advanced Biopsy Devices
      • Availability of Advanced Diagnostic Services
    • OPPORTUNITIES/CHALLENGES
      • Tapping the Diagnostic Market Present in Emerging Economies
        • TABLE 3: PERCENTAGE OF THE AGING POPULATION IN DEVELOPING COUNTRIES, 2014 (%)
        • FIGURE 2: PERCENTAGE OF THE AGING POPULATION IN DEVELOPING COUNTRIES, 2014 (%)
  • CASE STUDIES
    • CASE STUDY 1: BREAST TOMOSYNTHESIS BIOPSY (2011)
      • Company Involved: Hologic Inc.
    • CASE STUDY 2: PET-GUIDED BREAST BIOPSY (2011)
      • Company Involved: Naviscan Inc.
    • CASE STUDY 3: BIOPSY USED TO INFILTRATE DUCTAL CARCINOMA
      • Company Involved: Toshiba

CHAPTER 4 - BIOPSY DEVICE MARKET BY TYPE

  • TABLE 4: GLOBAL MARKET FOR BIOPSY DEVICES BY TYPE, THROUGH 2020 ($ MILLIONS)
  • BREAST BIOPSY DEVICES
    • STEREOTACTIC BIOPSIES
    • ULTRASOUND-GUIDED BIOPSIES
    • SURGICAL OR OPEN BIOPSIES
      • Surgical Biopsies with Needle Localization
        • TABLE 5: GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY TYPE, THROUGH 2020 ($ MILLIONS)
        • TABLE 6: TYPES OF BREAST BIOPSY AND MAMMOGRAPHY EQUIPMENT
        • TABLE 7: GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • VACUUM-ASSISTED BIOPSY DEVICES
      • TABLE 8: GLOBAL MARKET FOR VACUUM-ASSISTED BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
      • Breast Tissue Markers
        • Advantages of Vacuum-assisted Biopsy
        • Disadvantages of Vacuum-Assisted Biopsy
    • CAPITAL EQUIPMENT
    • IMAGE-GUIDED BREAST BIOPSIES
      • Ultrasound-Guided Breast Core Needle Biopsy
      • Stereotactic/MRI Breast Biopsy (Mammotome)
    • MAMMOGRAPHY
      • Digital Mammography
    • MAGNETIC RESONANCE IMAGING
      • Risks and Benefits of MRI
    • DISPOSABLE DEVICES
      • VAB Disposable Devices
        • Handheld Disposable Devices
      • Disposable Biopsy Punch
        • Punches with Plunger System
        • Punches without Plunger System
    • CORE NEEDLE BIOPSY
      • TABLE 9: GLOBAL MARKET FOR CORE NEEDLE BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
      • Core Needle Biopsy with Stereotactic Mammography
      • Advantages of Core Needle Biopsy
      • Disadvantages of Core Needle Biopsy
      • CNB Disposable Devices
        • Drapes
          • Table Drapes
          • Disposable Magnetic Drapes
          • Equipment Drape
        • Source Sleeve
        • Disposable Sterile Kit
      • CNB Tissue Markers
        • Advantages of CNB Tissue Markers
        • Disadvantages of CNB Markers
    • FINE NEEDLE ASPIRATION BIOPSY
      • TABLE 10: GLOBAL MARKET FOR FINE-NEEDLE ASPIRATION BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • GASTROINTESTINAL BIOPSY
    • TABLE 11: GLOBAL MARKET FOR GASTROINTESTINAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • COLD FORCEPS
    • HOT FORCEPS
  • SOFT TISSUE BIOPSY NEEDLES
    • TABLE 12: GLOBAL MARKET FOR SOFT TISSUE BIOPSY NEEDLES BY REGION, THROUGH 2020 ($ MILLIONS)
    • CORE NEEDLE BIOPSY NEEDLES
    • FINE-NEEDLE ASPIRATION NEEDLES
      • Advantages of FNA Needles
      • Disadvantages of FNA Needles
  • BRONCHIAL BIOPSY DEVICES
    • TABLE 13: GLOBAL MARKET FOR BRONCHIAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • FORCEPS
      • Disposable
      • Reusable
    • TBNA NEEDLES
      • Conventional Needles
    • EBUS-TBNA
  • GYNECOLOGICAL BIOPSY DEVICES
    • TABLE 14: GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • ENDOMETRIAL SAMPLERS
      • Functions of Endometrial Samplers
  • ROBOTIC GUIDANCE SYSTEMS
    • TABLE 15: GLOBAL MARKET FOR ROBOTIC GUIDANCE SYSTEMS BY REGION, THROUGH 2020 ($ MILLIONS)
    • NEUROMATE (RENISHAW)
      • Benefits of Neuromate
      • Safety Features of Neuromate
    • PATHFINDER (PROSURGICS)
    • INNOMOTION (INNOMEDIC)
  • OTHERS
    • TABLE 16: GLOBAL MARKET FOR OTHER BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • BIOPSY BRUSHES
    • BIOPSY CURETTES
      • TABLE 17: TYPES OF BIOPSY CURETTES
    • BIOPSY PUNCHES
      • TABLE 18: TYPES OF BIOPSY PUNCHES

CHAPTER 5 - BIOPSY DEVICE MARKET BY THERAPEUTIC AREA

  • TABLE 19: GLOBAL MARKET FOR BIOPSY DEVICES BY THERAPEUTIC AREA, THROUGH 2020 ($ MILLIONS)
  • TABLE 20: GLOBAL MARKET FOR BIOPSY DEVICE BY NUMBER OF PROCEDURES, THROUGH 2020 (THOUSANDS)
  • BREAST BIOPSY
    • FINE-NEEDLE ASPIRATION BIOPSY
      • Fine-Needle Aspiration Biopsy for Palpable Growth
      • Guided FNAB for Nonpalpable Growth
    • CORE NEEDLE BIOPSY
    • VACUUM-ASSISTED BIOPSIES
    • SURGICAL BIOPSY
      • TABLE 21: GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • GI BIOPSY
    • ENDOSCOPIC BIOPSY
    • FINE NEEDLE ASPIRATION BIOPSY
    • SURGICAL BIOPSY
      • TABLE 22: GLOBAL MARKET FOR GI BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • PROSTATE BIOPSY
    • LYMPH NODE BIOPSY
      • Laparoscopic Biopsy
      • Fine-Needle Aspiration Biopsy
      • Surgical Biopsy
        • TABLE 23: GLOBAL MARKET FOR PROSTATE BIOPSY DEVICES THROUGH 2020 ($ MILLIONS)
  • LIVER BIOPSY
    • NEEDLE BIOPSY
    • LAPAROSCOPIC BIOPSY
    • SURGICAL BIOPSY
      • TABLE 24: GLOBAL MARKET FOR LIVER BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • LUNG BIOPSY
      • TABLE 25: FIVE YEAR SURVIVAL RATES FOR NON-SMALL LUNG CANCER BY STAGE, 2013 (%)
      • FIGURE 3: FIVE-YEAR SURVIVAL RATE FOR NON-SMALL LUNG CANCER BY STAGE, 2013 (%)
  • ADVANTAGES OF LUNG BIOPSY
  • DISADVANTAGES OF LUNG BIOPSY
    • TABLE 26: GLOBAL MARKET FOR LUNG BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • KIDNEY BIOPSY
    • TABLE 27: INCIDENCE OF KIDNEY CANCER IN THE U.S. BY GENDER, 2014 (%)
    • FIGURE 4: INCIDENCE OF KIDNEY CANCER IN THE U.S. BY GENDER, 2014 (%)
    • COMPLICATIONS OF BIOPSIES TO DETECT KIDNEY DISEASE
    • ADVANTAGES OF RENAL/KIDNEY BIOPSY
    • DISADVANTAGES OF RENAL/KIDNEY BIOPSY
      • TABLE 28: GLOBAL MARKET FOR KIDNEY BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • GYNECOLOGICAL BIOPSY
    • TABLE 29: DISTRIBUTION OF GYNECOLOGICAL CANCERS IN THE U.S. BY TYPE, 2014
    • FIGURE 5: DISTRIBUTION OF GYNECOLOGICAL CANCERS IN THE U.S. BY TYPE, 2014
    • COMPLICATIONS OF GYNECOLOGICAL BIOPSY
      • TABLE 30: GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • BIOPSY DEVICES USED TO DIAGNOSE OTHER DISEASES
    • PANCREATIC CANCER BIOPSY
      • Types of Biopsies Performed to Detect Pancreatic Cancer
      • Percutaneous Needle Biopsy
      • Endoscopic Retrograde Cholangiopancreatography
      • Endoscopic Ultrasound
    • BILE DUCT CANCER BIOPSY
    • THYROID BIOPSY
      • TABLE 31: GLOBAL MARKET FOR OTHER THERAPEUTIC BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 6 - BIOPSY DEVICE MARKET BY IMAGE GUIDING TECHNOLOGY

  • TABLE 32: GLOBAL MARKET FOR BIOPSY DEVICES BY IMAGE GUIDING TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
  • IMAGING TECHNOLOGIES USED IN GUIDING BIOPSIES
    • MRI-GUIDED BREAST BIOPSY
      • Advantages of MRI-Guided Biopsy
        • TABLE 33: GLOBAL MARKET FOR MRI-GUIDED BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • STEREOTACTIC-GUIDED BREAST BIOPSY
      • Advantages of Stereotactic-Guided Needle Biopsy
      • Disadvantages/Limitations of Stereotactic-Guided Needle Biopsy
        • TABLE 34: GLOBAL MARKET FOR STEREOTACTIC GUIDED BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • ULTRASOUND-GUIDED BIOPSY
    • LIVER BIOPSY
    • THYROID BIOPSY
    • PROSTATE BIOPSY
    • BREAST BIOPSY
    • TRENDS
      • TABLE 35: GLOBAL MARKET FOR ULTRASOUND-GUIDED BREAST BIOPSY BY REGION, THROUGH 2020 ($ MILLIONS)
  • COMPUTED TOMOGRAPHY
    • ADVANTAGES OF CT-GUIDED NEEDLE BIOPSY
    • DISADVANTAGES OF CT-GUIDED NEEDLE BIOPSY
    • LIMITATIONS OF CT-GUIDED NEEDLE BIOPSY
      • TABLE 36: GLOBAL MARKET FOR CT-GUIDED BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • OTHERS
    • TABLE 37: GLOBAL MARKET FOR OTHER BIOPSY IMAGING DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 7 - END USER MARKETS FOR BIOPSY DEVICES

  • TABLE 38: GLOBAL MARKET FOR BIOPSY DEVICES BY END USER, THROUGH 2020 ($ MILLIONS)
  • DIAGNOSTIC CENTERS
    • TABLE 39: GLOBAL MARKET FOR BIOPSY DEVICES USED IN DIAGNOSTIC CENTERS BY REGION, THROUGH 2020 ($ MILLIONS)
  • HOSPITALS
    • TABLE 40: GLOBAL MARKET FOR BIOPSY DEVICES USED IN HOSPITALS AND SPECIALIZED CENTERS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: GLOBAL MARKET FOR BIOPSY DEVICES USED BY SPECIALIZED CENTERS AND HOSPITALS, THROUGH 2020 ($ MILLIONS)
  • SPECIALIZED (CANCER)
    • TABLE 42: GLOBAL MARKET FOR BIOPSY DEVICES USED IN SPECIALIZED CENTERS BY REGION, THROUGH 2020 ($ MILLIONS)
  • HOSPITALS
    • TABLE 43: GLOBAL MARKET FOR BIOPSY DEVICES USED IN HOSPITALS BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 8 - COMPETITIVE LANDSCAPE

  • FIGURE 6: DISTRIBUTION OF KEY COMPETITIVE STRATEGIES USED BY BIOPSY DEVICE COMPANIES, 2012-2015 (%)
  • PRODUCT LAUNCHES
    • FIGURE 7 DISTRIBUTION OF PRODUCT LAUNCH STRATEGY BY COMPANY, 2012-2015 (%)
    • TABLE 44: KEY PRODUCT LAUNCHES ANNOUNCED BETWEEN 2012 AND 2015
  • PARTNERSHIPS AND COLLABORATIONS
    • FIGURE 8: DISTRIBUTION OF THE PARTNERSHIP AND COLLABORATION STRATEGY BY COMPANY, 2012-2015 (%)
    • TABLE 45: PARTNERSHIP AND COLLABORATION STRATEGY BY COMPANY, 2012-2015
  • ACQUISITIONS
    • FIGURE 9: DISTRIBUTION OF THE ACQUISITION STRATEGY BY COMPANY, 2012-2015 (%)
    • TABLE 46: COMPANY ACQUISITIONS , 2012-2015
  • EXPANSIONS
    • TABLE 47: COMPANY EXPANSIONS, 2012-2015

CHAPTER 9 - BIOPSY DEVICE MARKET BY REGION

  • NORTH AMERICA
    • TABLE 48: NORTH AMERICAN MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
  • EUROPE
    • TABLE 49: EUROPEAN MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
  • ASIA-PACIFIC
    • TABLE 50: ASIA-PACIFIC MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
  • ROW
    • TABLE 51: ROW MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)

CHAPTER 10 - PATENT ANALYSIS

  • FIGURE 10: U.S., EUROPEAN AND JAPANESE SHARES OF PATENTS ON BIOPSY DEVICES, 2013-2015 (%)
  • U.S. PATENT ANALYSIS BY MARKET PARTICIPANT
    • FIGURE 11: U.S. PATENT SHARES BY MARKET PARTICIPANT, 2013-2015 (%)
  • EUROPEAN PATENT ANALYSIS BY MARKET PARTICIPANT
    • FIGURE 12: EUROPEAN PATENT SHARES BY MARKET PARTICIPANT, 2015 (%)
  • JAPANESE PATENT ANALYSIS BY MARKET PARTICIPANT
    • FIGURE 13: JAPANESE PATENT SHARES BY MARKET PARTICIPANT, 2013-2015 (%)

CHAPTER 11 - COMPANY PROFILES

  • ARGON MEDICAL DEVICES INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 52: ARGON MEDICAL DEVICES: RECENT DEVELOPMENTS
  • BECTON DICKINSON AND CO. (CAREFUSION CORP.)
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 53: BECTON DICKINSON (CAREFUSION): RECENT DEVELOPMENTS
      • TABLE 54: BECTON DICKINSON FINANCIALS ($ MILLIONS)
  • BOSTON SCIENTIFIC CORP.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 55: BOSTON SCIENTIFIC: RECENT DEVELOPMENTS
      • TABLE 56: BOSTON SCIENTIFIC FINANCIALS ($ MILLIONS)
  • C. R. BARD INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 57: C. R. BARD FINANCIALS ($ MILLIONS)
  • CARDINAL HEALTH INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 58: CARDINAL HEALTH: RECENT DEVELOPMENTS
      • TABLE 59: CARDINAL HEALTH FINANCIALS ($ MILLIONS)
  • COOK MEDICAL INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 60: COOK MEDICAL: RECENT DEVELOPMENTS
  • DTR MEDICAL LTD.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 61: DTR MEDICAL: RECENT DEVELOPMENTS
  • ETHICON ENDO-SURGERY INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 62: ETHICON ENDO-SURGERY: RECENT DEVELOPMENTS
      • TABLE 63: ETHICON ENDO-SURGERY (JOHNSON & JOHNSON) FINANCIALS ($ BILLIONS)
  • FUJIFILM HOLDINGS CORP.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 64: FUJIFILM HOLDINGS: RECENT DEVELOPMENTS
      • TABLE 65: FUJIFILM HOLDINGS FINANCIALS ($ MILLIONS)
  • HOLOGIC INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 66: HOLOGIC: RECENT DEVELOPMENTS
      • TABLE 67: HOLOGIC FINANCIALS ($ MILLIONS)
  • INRAD INC.
    • BIOPSY PRODUCT PORTFOLIO
  • INTACT MEDICAL CORP.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 68: INTACT MEDICAL: RECENT DEVELOPMENTS
  • LEICA BIOSYSTEMS (DEVICOR MEDICAL PRODUCTS)
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 69: LEICA BIOSYSTEMS (DEVICOR MEDICAL): RECENT DEVELOPMENTS
  • MAUNA KEA TECHNOLOGIES
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 70: MAUNA KEA TECHNOLOGIES: RECENT DEVELOPMENTS
      • TABLE 71: MAUNA KEA TECHNOLOGIES FINANCIALS ($ MILLIONS)
  • MDNA LIFE SCIENCES INC. (MITOMICS INC.)
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 72: MDNA LIFE SCIENCES (MITOMICS): RECENT DEVELOPMENTS
  • MDXHEALTH INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 73: MDXHEALTH: RECENT DEVELOPMENTS
  • MEDTRONIC
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 74: MEDTRONIC: RECENT DEVELOPMENTS
      • TABLE 75: MEDTRONIC FINANCIALS ($ MILLIONS)
  • SANARUS TECHNOLOGIES LLC
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 76: SANARUS TECHNOLOGIES LLC: RECENT DEVELOPMENTS
  • VERAN MEDICAL TECHNOLOGIES
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 77: VERAN MEDICAL TECHNOLOGIES: RECENT DEVELOPMENTS

CHAPTER 12 - APPENDIX

  • TABLE 78: LIST OF NORTH AMERICAN PATENTS ON BIOPSY DEVICES, 2013-2015
  • TABLE 79: LIST OF EUROPEAN PATENTS ON BIOPSY DEVICES, 2013-2015
  • TABLE 80: LIST OF JAPANESE PATENTS ON BIOPSY DEVICES, 2013-2015

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 1: IMPLEMENTATION OF BREAST CANCER SCREENING PROGRAMS BY COUNTRY
    • TABLE 2: GLOBAL TRENDS IN AGING POPULATION BY REGION, 1980-2040 (%)
    • TABLE 3: PERCENTAGE OF THE AGING POPULATION IN DEVELOPING COUNTRIES, 2014 (%)
    • TABLE 4: GLOBAL MARKET FOR BIOPSY DEVICES BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 5: GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 6: TYPES OF BREAST BIOPSY AND MAMMOGRAPHY EQUIPMENT
    • TABLE 7: GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 8: GLOBAL MARKET FOR VACUUM-ASSISTED BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 9: GLOBAL MARKET FOR CORE NEEDLE BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 10: GLOBAL MARKET FOR FINE-NEEDLE ASPIRATION BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 11: GLOBAL MARKET FOR GASTROINTESTINAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 12: GLOBAL MARKET FOR SOFT TISSUE BIOPSY NEEDLES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 13: GLOBAL MARKET FOR BRONCHIAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 14: GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 15: GLOBAL MARKET FOR ROBOTIC GUIDANCE SYSTEMS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 16: GLOBAL MARKET FOR OTHER BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 17: TYPES OF BIOPSY CURETTES
    • TABLE 18: TYPES OF BIOPSY PUNCHES
    • TABLE 19: GLOBAL MARKET FOR BIOPSY DEVICES BY THERAPEUTIC AREA, THROUGH 2020 ($ MILLIONS)
    • TABLE 20: GLOBAL MARKET FOR BIOPSY DEVICE BY NUMBER OF PROCEDURES, THROUGH 2020 (THOUSANDS)
    • TABLE 21: GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 22: GLOBAL MARKET FOR GI BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 23: GLOBAL MARKET FOR PROSTATE BIOPSY DEVICES THROUGH 2020 ($ MILLIONS)
    • TABLE 24: GLOBAL MARKET FOR LIVER BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 25: FIVE YEAR SURVIVAL RATES FOR NON-SMALL LUNG CANCER BY STAGE, 2013 (%)
    • TABLE 26: GLOBAL MARKET FOR LUNG BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 27: INCIDENCE OF KIDNEY CANCER IN THE U.S. BY GENDER, 2014 (%)
    • TABLE 28: GLOBAL MARKET FOR KIDNEY BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 29: DISTRIBUTION OF GYNECOLOGICAL CANCERS IN THE U.S. BY TYPE, 2014
    • TABLE 30: GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 31: GLOBAL MARKET FOR OTHER THERAPEUTIC BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 32: GLOBAL MARKET FOR BIOPSY DEVICES BY IMAGE GUIDING TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 33: GLOBAL MARKET FOR MRI-GUIDED BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 34: GLOBAL MARKET FOR STEREOTACTIC GUIDED BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 35: GLOBAL MARKET FOR ULTRASOUND-GUIDED BREAST BIOPSY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 36: GLOBAL MARKET FOR CT-GUIDED BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 37: GLOBAL MARKET FOR OTHER BIOPSY IMAGING DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 38: GLOBAL MARKET FOR BIOPSY DEVICES BY END USER, THROUGH 2020 ($ MILLIONS)
    • TABLE 39: GLOBAL MARKET FOR BIOPSY DEVICES USED IN DIAGNOSTIC CENTERS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 40: GLOBAL MARKET FOR BIOPSY DEVICES USED IN HOSPITALS AND SPECIALIZED CENTERS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: GLOBAL MARKET FOR BIOPSY DEVICES USED BY SPECIALIZED CENTERS AND HOSPITALS, THROUGH 2020 ($ MILLIONS)
    • TABLE 42: GLOBAL MARKET FOR BIOPSY DEVICES USED IN SPECIALIZED CENTERS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 43: GLOBAL MARKET FOR BIOPSY DEVICES USED IN HOSPITALS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 44: KEY PRODUCT LAUNCHES ANNOUNCED BETWEEN 2012 AND 2015
    • TABLE 45: PARTNERSHIP AND COLLABORATION STRATEGY BY COMPANY, 2012-2015
    • TABLE 46: COMPANY ACQUISITIONS , 2012-2015
    • TABLE 47: COMPANY EXPANSIONS, 2012-2015
    • TABLE 48: NORTH AMERICAN MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 49: EUROPEAN MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 50: ASIA-PACIFIC MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 51: ROW MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 52: ARGON MEDICAL DEVICES: RECENT DEVELOPMENTS
    • TABLE 53: BECTON DICKINSON (CAREFUSION): RECENT DEVELOPMENTS
    • TABLE 54: BECTON DICKINSON FINANCIALS ($ MILLIONS)
    • TABLE 55: BOSTON SCIENTIFIC: RECENT DEVELOPMENTS
    • TABLE 56: BOSTON SCIENTIFIC FINANCIALS ($ MILLIONS)
    • TABLE 57: C. R. BARD FINANCIALS ($ MILLIONS)
    • TABLE 58: CARDINAL HEALTH: RECENT DEVELOPMENTS
    • TABLE 59: CARDINAL HEALTH FINANCIALS ($ MILLIONS)
    • TABLE 60: COOK MEDICAL: RECENT DEVELOPMENTS
    • TABLE 61: DTR MEDICAL: RECENT DEVELOPMENTS
    • TABLE 62: ETHICON ENDO-SURGERY: RECENT DEVELOPMENTS
    • TABLE 63: ETHICON ENDO-SURGERY (JOHNSON & JOHNSON) FINANCIALS ($ BILLIONS)
    • TABLE 64: FUJIFILM HOLDINGS: RECENT DEVELOPMENTS
    • TABLE 65: FUJIFILM HOLDINGS FINANCIALS ($ MILLIONS)
    • TABLE 66: HOLOGIC: RECENT DEVELOPMENTS
    • TABLE 67: HOLOGIC FINANCIALS ($ MILLIONS)
    • TABLE 68: INTACT MEDICAL: RECENT DEVELOPMENTS
    • TABLE 69: LEICA BIOSYSTEMS (DEVICOR MEDICAL): RECENT DEVELOPMENTS
    • TABLE 70: MAUNA KEA TECHNOLOGIES: RECENT DEVELOPMENTS
    • TABLE 71: MAUNA KEA TECHNOLOGIES FINANCIALS ($ MILLIONS)
    • TABLE 72: MDNA LIFE SCIENCES (MITOMICS): RECENT DEVELOPMENTS
    • TABLE 73: MDXHEALTH: RECENT DEVELOPMENTS
    • TABLE 74: MEDTRONIC: RECENT DEVELOPMENTS
    • TABLE 75: MEDTRONIC FINANCIALS ($ MILLIONS)
    • TABLE 76: SANARUS TECHNOLOGIES LLC: RECENT DEVELOPMENTS
    • TABLE 77: VERAN MEDICAL TECHNOLOGIES: RECENT DEVELOPMENTS
    • TABLE 78: LIST OF NORTH AMERICAN PATENTS ON BIOPSY DEVICES, 2013-2015
    • TABLE 79: LIST OF EUROPEAN PATENTS ON BIOPSY DEVICES, 2013-2015
    • TABLE 80: LIST OF JAPANESE PATENTS ON BIOPSY DEVICES, 2013-2015

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, 2014-2020 ($ MILLIONS)
    • FIGURE 1: GLOBAL TRENDS IN AGING POPULATION, 1980-2040 (%)
    • FIGURE 2: PERCENTAGE OF THE AGING POPULATION IN DEVELOPING COUNTRIES, 2014 (%)
    • FIGURE 3: FIVE-YEAR SURVIVAL RATE FOR NON-SMALL LUNG CANCER BY STAGE, 2013 (%)
    • FIGURE 4: INCIDENCE OF KIDNEY CANCER IN THE U.S. BY GENDER, 2014 (%)
    • FIGURE 5: DISTRIBUTION OF GYNECOLOGICAL CANCERS IN THE U.S. BY TYPE, 2014
    • FIGURE 6: DISTRIBUTION OF KEY COMPETITIVE STRATEGIES USED BY BIOPSY DEVICE COMPANIES, 2012-2015 (%)
    • FIGURE 7: DISTRIBUTION OF PRODUCT LAUNCH STRATEGY BY COMPANY, 2012-2015 (%)
    • FIGURE 8: DISTRIBUTION OF THE PARTNERSHIP AND COLLABORATION STRATEGY BY COMPANY, 2012-2015 (%)
    • FIGURE 9: DISTRIBUTION OF THE ACQUISITION STRATEGY BY COMPANY, 2012-2015 (%)
    • FIGURE 10: U.S., EUROPEAN AND JAPANESE SHARES OF PATENTS ON BIOPSY DEVICES, 2013-2015 (%)
    • FIGURE 11: U.S. PATENT SHARES BY MARKET PARTICIPANT, 2013-2015 (%)
    • FIGURE 12: EUROPEAN PATENT SHARES BY MARKET PARTICIPANT, 2015 (%)
    • FIGURE 13: JAPANESE PATENT SHARES BY MARKET PARTICIPANT, 2013-2015 (%)
Back to Top